Pune: A policy on the dose of booster is likely to be announced at the end of this month, but its priority is to complete the earliest adult vaccination program, said a member of the Senior National Task Force on Saturday.
The National Technical Advisory Group concerning Immunization (Ntagi), the Government Advisory Agency of Immunization, will complete the policy.
“Comprehensive policies are likely to be out based on Indian epidemiology and the situation of the pandemic in the country and are not based on other countries.
Meeting must be held in the next two weeks,” said a member of the Task Force on developments.
He said even when the policy was being purchased, encouragement would, however, accelerate and complete an adult vaccination program.
The focus is to ensure that at least all adult beneficiaries are given the first dose on December 31.
At present, more than 80% of adult populations have received at least the first dose of vaccines, and more than 41% have obtained both.
shot.
In a recent meeting, most countries demanded Booster Shots for health workers.
Maharashtra Health Minister Rajesh Tope, too, has been given to the same thing.
Dr.
Samiran Panda, Head of the Epidemiology Division and Infectious Disease in the Indian Medical Research Council (ICMR), said that in discussions about the dose of booster or third shots, it is important that someone is not transferred from the two-dose public health program.
“We should not distract from existing policies and programmed actions to ensure that all adult populations get vaccine doses in the form of intramuscular injection,” he said.
He also said that the discussion of policies and programs around the third dose would take advantage of scientific evidence.
“These discussions should not attract our attention from the vaccination of two doses (programs), as we currently have not yet reached 80% coverage with vaccination doses,” he said.
ICMR scientists repeated that the ongoing two-dose vaccination program in this country has demonstrated efficacy in the form of reducing the severity of the disease, and the possibility of death after the acquisition of SARS-COV-2 infection.
“Discussions around the third dose are related to those who, because immunosuppression conditions, cannot install immunity.
In connection with the decision of the public health program in the country, while Ntagi serves as a advisory body, department and related ministry leading policy formulation,” he told TII.
Leading Virology Dr.
Jacob John said the science of vaccine and epidemiology of Covid (infection of immunity and breakthroughs and breakthroughs -Mead disorder among others.